Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.

MLA

Kong, Liang, et al. “Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice.” International Journal of Nanomedicine, vol. 15, Apr. 2020, pp. 2841–58. EBSCOhost, https://doi.org/10.2147/IJN.S239608.

APA

Kong, L., Li, X.-T., Ni, Y.-N., Xiao, H.-H., Yao, Y.-J., Wang, Y.-Y., Ju, R.-J., Li, H.-Y., Liu, J.-J., Fu, M., Wu, Y.-T., Yang, J.-X., & Cheng, L. (2020). Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice. International Journal of Nanomedicine, 15, 2841–2858. https://doi.org/10.2147/IJN.S239608

Chicago

Kong, Liang, Xue-Tao Li, Ying-Nan Ni, Hong-He Xiao, Ying-Jia Yao, Yuan-Yuan Wang, Rui-Jun Ju, et al. 2020. “Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice.” International Journal of Nanomedicine 15 (April): 2841–58. doi:10.2147/IJN.S239608.